Cutler Group LP Ascendis Pharma A/S Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Cutler Group LP holds 440 shares of ASND stock, worth $57,116. This represents 0.02% of its overall portfolio holdings.

Number of Shares

440

Holding current value

$57,116

% of portfolio

0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$123.45 - $159.4 $54,318 - $70,136	440 New	440 $66,000
Q3 2023 Nov 07, 2023	SELL	$86.5 - $103.97 $39,790 - $47,826	-460 Reduced 69.7%	200 $18,000
Q2 2023 Jul 18, 2023	BUY	$69.96 - $97.84 $35,679 - $49,898	510 Added 340.0%	660 $58,000
Q1 2023 May 01, 2023	SELL	$104.9 - $126.78 $5,245 - $6,339	-50 Reduced 25.0%	150 $16,000
Q4 2022 Feb 07, 2023	BUY	$99.42 - $131.97 $19,884 - $26,394	200 New	200 $24,000
Q2 2022 Aug 04, 2022	SELL	$78.08 - $117.61 $615,504 - $927,119	-7,883 Reduced 81.65%	1,772 $164,000
Q1 2022 Apr 14, 2022	BUY	$102.18 - $135.75 $986,547 - $1.31 Million	9,655 New	9,655 $1.13 Million
Q4 2021 Jan 18, 2022	SELL	$127.1 - $169.66 $19,065 - $25,449	-150 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$112.67 - $176.92 $30,420 - $47,768	-270 Reduced 64.29%	150 $23,000
Q3 2020 Oct 27, 2020	SELL	$134.29 - $154.32 $212,178 - $243,825	-1,580 Reduced 79.0%	420 $64,000
Q1 2020 May 07, 2020	BUY	$97.01 - $145.11 $77,608 - $116,088	800 Added 66.67%	2,000 $225,000
Q4 2018 Feb 05, 2019	BUY	$55.16 - $69.67 $22,064 - $27,868	400 Added 50.0%	1,200 $75,000
Q2 2018 Aug 10, 2018	BUY	$58.55 - $73.92 $46,840 - $59,136	800 New	800 $53,000

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.26 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$666 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$648 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$573 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$543 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.24B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account